Lacouture ME - Search Results

1

Treatment Outcomes of Immune-Related Cutaneous Adverse Events.

Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, Chan D, Dusza S, Motzer RJ, Rosenberg JE, Callahan MK, Chapman PB, Geskin L, Lopez AT, Reed VA, Fabbrocini G, Annunziata MC, Kukoyi O, Pabani A, Yang CH, Chung WH, Markova A, Lacouture ME. Phillips GS, et al. Among authors: lacouture me. J Clin Oncol. 2019 Oct 20;37(30):2746-2758. doi: 10.1200/JCO.18.02141. Epub 2019 Jun 19. J Clin Oncol. 2019. PMID: 31216228 Free PMC article.

2

Dermatologic toxicities of targeted anticancer therapies.

Balagula Y, Lacouture ME, Cotliar JA. Balagula Y, et al. Among authors: lacouture me. J Support Oncol. 2010 Jul-Aug;8(4):149-61. J Support Oncol. 2010. PMID: 20822032 Review.

3

Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886).

Balagula Y, Barth Huston K, Busam KJ, Lacouture ME, Chapman PB, Myskowski PL. Balagula Y, et al. Among authors: lacouture me. Invest New Drugs. 2011 Oct;29(5):1114-21. doi: 10.1007/s10637-010-9567-3. Epub 2010 Oct 27. Invest New Drugs. 2011. PMID: 20978926 Free PMC article.

4

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors.

Balagula Y, Garbe C, Myskowski PL, Hauschild A, Rapoport BL, Boers-Doets CB, Lacouture ME. Balagula Y, et al. Among authors: lacouture me. Int J Dermatol. 2011 Feb;50(2):129-46. doi: 10.1111/j.1365-4632.2010.04791.x. Int J Dermatol. 2011. PMID: 21244375 Review.

5

The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis.

Balagula Y, Wu S, Su X, Lacouture ME. Balagula Y, et al. Among authors: lacouture me. Ann Oncol. 2011 Nov;22(11):2366-2374. doi: 10.1093/annonc/mdr016. Epub 2011 Mar 14. Ann Oncol. 2011. PMID: 21402620 Free article. Review.

6

The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies.

Balagula Y, Rosen ST, Lacouture ME. Balagula Y, et al. Among authors: lacouture me. J Am Acad Dermatol. 2011 Sep;65(3):624-635. doi: 10.1016/j.jaad.2010.06.051. Epub 2011 Jul 20. J Am Acad Dermatol. 2011. PMID: 21777992 Review.

7

Induction of cutaneous squamous cell carcinomas by RAF inhibitors: cause for concern?

Lacouture ME, O'Reilly K, Rosen N, Solit DB. Lacouture ME, et al. J Clin Oncol. 2012 Jan 20;30(3):329-30. doi: 10.1200/JCO.2011.38.2895. Epub 2011 Nov 7. J Clin Oncol. 2012. PMID: 22067405 No abstract available.

8

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

Balagula Y, Rosen A, Tan BH, Busam KJ, Pulitzer MP, Motzer RJ, Feldman DR, Konner JA, Reidy-Lagunes D, Myskowski PL, Lacouture ME. Balagula Y, et al. Among authors: lacouture me. Cancer. 2012 Oct 15;118(20):5078-83. doi: 10.1002/cncr.27505. Epub 2012 Mar 21. Cancer. 2012. PMID: 22437824 Free article.

9

Rash to the mTOR inhibitor everolimus: systematic review and meta-analysis.

Ramirez-Fort MK, Case EC, Rosen AC, Cerci FB, Wu S, Lacouture ME. Ramirez-Fort MK, et al. Among authors: lacouture me. Am J Clin Oncol. 2014 Jun;37(3):266-71. doi: 10.1097/COC.0b013e318277d62f. Am J Clin Oncol. 2014. PMID: 23241507 Review.

10

Skin care for cancer patients.

Lacouture ME. Lacouture ME. Clin Adv Hematol Oncol. 2012 Nov;10(11):748-50. Clin Adv Hematol Oncol. 2012. PMID: 23271263 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page